Beta thalassemia is an autosomal blood disorder (recessive in most cases) in which the production of haemoglobin, a protein that carries oxygen in red blood cells, is reduced. This leads to anaemia, which in turn causes fatigue, weakness, pale skin, and delayed growth in children.

Severe cases may result in bone deformities, an enlarged spleen, and heart complications. If not treated on time, it will progress to severe anaemia, growth and developmental retardation, and serious, even life-endangering complications such as heart failure, hepatic disease, and infections.

Treatment modalities for beta thalassemia are mostly based on its severity and typically include frequent blood transfusions, iron-chelating therapy against excessive iron absorption, and bone marrow or stem-cell transfusions, which can cure the disease. Early diagnosis and comprehensive care lead to symptomatic management and improved quality of life.

What is beta-thalassemia?

Beta thalassemia belongs to a group of hereditary anaemias associated with abnormal haemoglobin formation the protein of red blood cells that carries oxygen. It presents gene defects at the level of beta-globin chain genes, resulting in either a reduced or complete absence of their synthesis. The overall effect is low production of normal haemoglobin and, therefore, a variable degree of anaemia.

Symptoms of Beta Thalassemia

Beta-thalassemia symptoms can vary depending on the type and severity of the condition. Common signs and symptoms may include:

Fatigue and weakness
Pale skin
Shortness of breath
Slow growth and development in children
Bone deformities
Enlarged spleen and liver
Jaundice
Frequent infections

Individuals need to consult a healthcare provider if any of these symptoms are present, as early diagnosis and management are key to improving the quality of life for individuals with beta-thalassemia.

Causes of Beta Thalassemia

Beta-thalassemia is caused by mutations in the HBB gene, which provides instructions for making beta-globin, a component of haemoglobin.
These mutations can lead to reduced or absent production of beta-globin, resulting in abnormal haemoglobin production.
The inheritance pattern of beta thalassemia is autosomal recessive, meaning that both parents must pass on a copy of the mutated gene for a child to develop the disorder.

What Are the Treatment Options for Beta Thalassemia?

Treatment for beta thalassemia aims to manage symptoms, maintain healthy haemoglobin levels, and prevent complications. Some common treatment options include:

Blood transfusions: Regular transfusions can help replace the deficient haemoglobin in beta-thalassemia patients.
Iron chelation therapy: Since frequent blood transfusions can lead to iron overload, chelation therapy removes excess iron from the body.
Folic acid supplements: Folic acid helps produce red blood cells and can benefit individuals with beta-thalassemia.
Bone marrow transplant: In severe cases, a bone marrow transplant may be considered a curative treatment option for beta-thalassemia.
Prevention: Prevention is better than to treat the thalassemia patients. Screening by HPLC - pre marital on the best measure.

Conclusion

Beta-thalassemia is a genetic disorder that needs lifelong management. Knowledge about the symptoms, causes, and treatment of beta-thalassemia helps the affected person and his or her health provider optimise care and improve quality of life. Effective management depends on early diagnosis, regular follow-up, and compliance with treatment plans.

References

https://www.mayoclinic.org/diseases-conditions/thalassemia/symptoms-causes/syc-20354995
https://my.clevelandclinic.org/health/diseases/23574-beta-thalassemia